About The Study: Among patients diagnosed with cancer in California and Georgia between 2013 and 2019, only 6.8% underwent germline genetic ...
CHICAGO – Patients with early relapsed or refractory large B-cell lymphoma had significantly improved overall survival when treated with the chimeric ...
ABSTRACTS: 3121, 4504, LBA4619 Credit: MD Anderson Cancer Center ABSTRACTS: 3121, 4504, LBA4619 CHICAGO ― Three clinical trials led by ...
In a new study of trastuzumab deruxtecan, a HER2-targeted antibody drug conjugate, researchers observed encouraging responses and long-lasting clinical benefit ...
About The Study: The findings of this study provide reassurance that for patients with advanced non–small cell lung cancer whose disease ...
ABSTRACT: 4008 Credit: MD Anderson Cancer Center ABSTRACT: 4008 CHICAGO ― HER2-targeted bispecific antibody zanidatamab demonstrated durable responses in patients ...
A study involving UCLA Jonsson Comprehensive Cancer Center researchers found when ribociclib, a targeted therapy drug, is added to hormone ...
Sarcomas Dr. Jonathan C. Trent, a medical oncologist specializing in Sarcoma and Connective Tissue Medical Oncology at Sylvester, is available ...
DOWNLOADABLE B-ROLL/VIDEO Credit: Sylvester Comprehensive Cancer Center DOWNLOADABLE B-ROLL/VIDEO MIAMI, FLORIDA (June 1, 2023) – Historically, surgery was the ...
MIAMI, FLORIDA (May 30, 2023) – Dr. Gilberto Lopes has a passion for equitable cancer care that extends far beyond ...
ABSTRACT: 7003 Treatment with luspatercept improved red blood cell counts and erythroid responses compared to treatment with epoetin alfa in ...
CHICAGO ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research ...
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, ...
CHICAGO – Researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will present ...
Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center will discuss the latest research and clinical trial results on ...
BIRMINGHAM, Ala. – All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the ...
CHICAGO ― Eduardo Bruera, M.D., chair of Palliative Care Medicine at The University of Texas MD Anderson Cancer Center, has ...
Philadelphia, May 27, 2022—Researchers with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present a wide range of study results at ...
OAKLAND, CA – MAY 26, 2022 – Kaiser Permanente, which cares for more than 500,000 cancer patients every year, will ...
Boston – Several phase 3 studies conducted by researchers from Dana-Farber Cancer Institute show promising results for patients with multiple ...
